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SUMMARY: The ricinoleate triglyceride was extracted from castor-oil seeds grown in Algeria and isolated by 
catalytically methanolyse to methyl ricinoleate. Six diazole and triazole derivatives of ricinoleic acid were synthesized 
and characterized: 1,3,4-oxadiazole-5-thione (4); 1,3,4-thiadiazole-5-thione (5); 4-N-amino-1,2,4-triazole-5-thiol 
(7); 1,2,4-triazole-5-thione (9); 5-amino-1,3,4-oxadiazole (10) and 5-amino-1,3,4-thiadiazole (11). The antibacterial 
and antifungal screening data of synthesized compounds showed appreciable inhibition and among them, 5, 7 and 
8 showed more inhibition on Gram positive Enterococcus faecalis than reference ampiciline; while compounds 1, 7, 
8, 10 and 11 showed competitive antifungal effects compared to reference amphotericin B. In addition, all synthe-
sized compounds (1-11) showed competitive antioxidant properties, particularly compounds 7 at 125, 250, 500 and 
1000 µg/mL and compounds 4, 5 and 9 at a concentration of 1000 µg/mL. The intermediate compounds 1, 2 and 
8 showed anti-α-amylase activity at various concentrations in the range of IC50 = (120.25 ± 1.17 - 130.42 ± 2.48). 
Oxadiazole 4 showed the best α-amylase inhibition by 78.5% at a concentration of 1000 μg/mL.
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RESUMEN: Diazoles y triazoles derivados del extracto de aceite de ricino: síntesis, efecto hipoglucémico, potencial 
antioxidante y actividad antimicrobiana. Los triglicéridos de ricinoleico se extrajeron de semillas de aceite de 
ricino cultivadas en Argelia y se sintetizó catalíticamente con metanolisis el ricinoleato de metilo. Seis deriva-
dos de diazoles y triazoles de ácido ricinoleico se han sintetizado y caracterizado: 1,3,4-oxadiazol-5-tiona (4), 
1,3,4-tiadiazol-5-tiona (5), 4-N-amino-1,2,4-triazol-5-tiol (7), 1,2,4-triazol-5-tiona (9), 5-amino-1,3,4-oxadia-
zol (10) y 5-amino-1,3,4-tiadiazol (11). Los datos de detección antibacteriana y antifúngica de los compuestos 
sintetizados mostraron una inhibición apreciable, entre ellos, los compuestos 5, 7 y 8 mostraron más inhibición 
en Enterococcus faecalis Gram positivo que la ampicilina de referencia. Mientras que los compuestos 1, 7, 8, 
10 y 11 mostraron una influencia antifúngica competitiva en comparación con la anfotericina de referencia B. 
Como todos los compuestos sintetizados (1-11) mostraron propiedades antioxidantes competitivas, particu-
larmente los compuestos 7, a 125, 250, 500 y 1000 μg/mL también compuestos 4, 5 y 9 a una concentración de 
1000 μg/mL. Los compuestos intermedios 1, 2 y 8 mostraron actividad anti-α-amilasa a diversas concentra-
ciones en el rango de IC50 = (120.25 ± 1.17 - 130.42 ± 2.48). El oxadiazol 4 mostró la mejor inhibición de la 
α-amilasa en un 78.5% a una concentración de 1000 μg/mL.
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1. INTRODUCTION
Castor oil is a natural production of the cas-
tor plant (Ricinus Communis) (Mubofu, 2016). 
Castor oil plants are widespread throughout the 
globe, particularly in tropical regions such as India, 
the southeastern Mediterranean Basin of North 
Africa (Trochain, 1930), Los Angeles, California 
(Witchard, 1997) and elsewhere. Castor oil has 
many uses; for example, it remains of commercial 
importance as a non-freezing, antimicrobial, pres-
sure-resistant lubricant for special purposes, either 
for latex or metals, or as a lubricating component 
in fuels (Imankulov, 2012). Castor oil has long been 
used on the skin to prevent dryness. Whether pure 
or processed, it is still a component of many cosmet-
ics (Bianchi et al., 2011; Rachapudi et al., 2017). 
The high percentage of ricinoleic acid residues 
in castor oil and their derivatives inhibit virus, bac-
teria or fungi (Ghosh et al., 2013). The literature 
has revealed several synthetic modifications and 
utilization of ricinoleic acid. These modifications 
vary between ethylenic bond (Godard et al., 2013) 
hydroxyl group (Thames et al., 2006) and carboxylic 
acid group (Dutta et al., 2011; Lavanya et al., 2012). 
Heterocyclic-fatty acid hybrids such as oxadia-
zole, thiadiazole and triazole derivatives of vegeta-
ble oils are a new class of fatty acid derivatives with 
a wide range of biological activities and significance 
in the field of medicinal chemistry. They possess a 
broad spectrum of therapeutic uses such as analge-
sic, antimicrobial, anti HIV activity, antitumor, anti-
malarial, anticancer, anticonvulsant, anti-diabetic, 
antioxidant (Cao et al., 2014; Ahmad et al., 2017).
This work is mainly concerned with the extrac-
tion of castor oil from seeds of the plant and the 
isolation of ricinoleic acid. The latter was subjected 
to synthetic modifications focused on the carbox-
ylic group to ultimately give six diazole derivatives. 
The synthetic intermediates and final products were 
studied to determine the biological evaluation of 
their α-amylase inhibitory, antimicrobial and anti-
oxidant activities.
2. MATERIALS AND METHODS
2.1. General
All reactions were monitored by TLC, silica gel 
F254, made by Merck, Germany. Melting points 
(ºC) were measured in open glass capillaries using a 
Branstead 9001 Electrothermal melting point appa-
ratus and were not corrected. The UV visible elec-
tron spectroscopy was recorded on an Optisen View 
4.2 spectrometer. The IR spectra were recorded 
using KBr disks in a GENESISIIFTIR spectropho-
tometer, in ν units of cm−1. The 1H and 13C-NMR 
spectra (1D) were recorded on a Bruker AC 400 
MHz spectrometer (University of Lyon 1, France) 
in DMSO-d6 and referenced to TMS. Symbols δ were 
used for chemical sifts in ppm, s = singlet, d = dou-
blet, dd = double doublet and m = multiplets. Mass 
spectra were obtained using a GC-MS CLARIS 500 
(Laboratoire Régional de Police Scientifique d’Oran, 
Algeria). The microorganisms in this study were sup-
plied and identified by the laboratory of microbiol-
ogy by the university hospital of Oran1. The Mueller 
Hinton medium was supplied by (Difco).
2.2. Chemistry
2.2.1. Oil extraction 
The castor oil (1) was extracted with a soxhlet 
extractor. Hexane (1L) and ground castor beans 
(200  g) were packed into a filter paper thimble. 
The  extraction lasted 10 h. The crude oil was 
treated  with hot water to remove gums, hydrates, 
phosphates and other impurities and then it was 
neutralized with 0.1N NaOH to remove free fatty 
acid and soap to give castor oil (1), (84 g, 40.2%) 
(Nakarmi et al., 2014). UV (λmax) nm: 205; 210. IR 
(CCl4), ν cm-1: 3452. 92(OH); 3008 (CH unsaturated); 
2925, 2855 (alkyl groups); 1742.37(C = O). 1H NMR 
(400 MHZ, DMSO d6) δ  (ppm): 5.37-5.34 (m, 6H, 
CHalkenes); 5.19-5.14 (m, 1H, C-Hβ); 4.34 (dd, 2H, 
C-Hα); 4.10 (dd, 2H, C-Hγ);  3.40(s, 3H, 3OH); 
2.06 (m, 6H, OCOCH3); 2.24-1.50 (m, 96H, CH 
paraffinic); 0.82 (m, 9H, CH3 terminal). 
13C NMR 
(400 MHZ, DMSO d6) δ ppm: 172.13; 132.1; 126.5; 
79.1; 69.8; 68.9; 61.6; 39.9; 39.7; 39.4; 39.1; 38.8; 
36.5; 35.1; 33.2; 31.4; 29.1; 29.0; 28.7; 28.6; 28.5; 
26.3; 26.2; 22.10; 13.80.
2.2.2. Methyl ricinoleate (2). Transesterification 
reaction 
The extracted oil (1) (25g; 0.028 mol) was kept 
in three necked round-bottom flasks and heated to 
65  ˚C. NaOH /MeOH (2,5g /20 mL) were added 
with the aid of stirring and the mixture was heated 
for three hours (Akhabue et al., 2017). The reaction 
was monitored by TLC (cyclohexane /acetone 8/2). 
After sampling, the reaction was stopped by acidi-
fying the mixture with concentrated HCl (37%) to 
neutralize the remaining alkali, and was allowed to 
stand for phase separation (for 24 h). The organic 
layer was left for phase separation 3 times and the 
collected fractions were dried on anhydrous CaCl2 
to give  methyl ricinoleate (24.5g, 98%); RF: 0.65 
(cyclohexane /acetone 8/2). UV (λmax) nm: 204. IR 
(CCl4), ν cm
 -1: 3430.74(OH); 3008(C = C); (2928.38 
and 2856) (alkyl groups); 3008(CH unsaturated); 
1737.55(C = O). 1H NMR (400 MHZ, DMSO 
d6) δ (ppm): (5.42; 5.38; 5.27) (m, 1H, H10 and H9); 
4.38(t, 3H,O-CH3); 4.01(t, 3H,O-CH3); 3.40(s, 1H, 
OH); 2.23-1.14  (m, 32H, CH paraffinic); 0.84; 
0.82 (t, 3H, CH3 terminal). 
13C NMR (400 MHZ, 
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DMSO d6) δ ppm: 175.0; 172.9; 130.8; 129.9; 127.8; 
70.4; 60.0; 35.6; 34.2; 31.2; 29.6; 29.5; 28.6; 28.6; 
27.5; 26.8; 22.9; 14.2. MS: Molecular formula 
C18H36O3: 311, m/z: 311 (M+, 100 %).
2.2.3. Ricinoleic acid hydrazide 
Methyl ricinoleate (2), (2.11 g; 0.01mol), etha-
nol (50  mL) and hydrazine hydrate 64% (12  mL) 
were  refluxed for 10  h. Ethanol and hydrazine 
were evaporated under reduced pressure, white 
solid was produced, recrystallized from acetone/
cyclohexane to give ricinoleic hydrazide (3), 2.2g, 
90%). M.p. (80–85  °C); UV (λmax) nm: 205; 262. 
IR (KBr), ν cm -1: 3323. 71 (OH, NH, NH2); 3008 
(HC = C); 2849.31 and 2918.73 (alkyl groups); 
1636. 3 (N-C = O). 1H NMR (400 MHZ, DMSO 
d6) δ (ppm): 8.88 (s, 1H, NH); 5.39 (m, 1H, H10); 5.37 
(m, 1H, H9); 3.34(s, 1H, OH); 4.37 (d, 2H, NH2); 
2.08-1.16 (m, 32H, CH paraffinic); 0.84 (t, 3H, CH3 
terminal). 13C NMR (400MHZ, DMSO d6) δ ppm: 
172.3; 128.4; 69.7; 37.9; 37.6; 34.2; 31.2; 29.6; 29.4; 
28.6; 25.6; 22.9; 21.9; 14.28. MS: Molecular for-
mula C18H36N2O: 312, m/z: 312 (M+, 100%).
2.2.4. 5-Ricinoleyl-1,3,4-oxadiazole-2-thione-thiol 
Ricinoleic acid hydrazide (3), (1g; 0.0032 mol) 
in ethanol (80 mL) was added to CS2 (30 mL) fol-
lowed by (1.2 g) KOH, and the mixture was refluxed 
for 16  h until the release of H2S had ceased. The 
mixture was then cooled and acidified with dilute 
HCl. The crude compound was recrystallized from 
chloroform to give 5-Ricinoleyl-1,3,4-oxadiazole-2-
thione-thiol  (4), (1.36  g, 70%), Rf: 0.64 (cyclohex-
ane /acetone 7/3); m.p. (117–120), UV (λmax) nm: 
205; 252. IR (KBr), ν cm -1: 3418. 21 (OH); 3222. 47 
(NH); (2957, 2868) (alkyl groups); 3046 (CH unsatu-
rated); 2800 (S-H); 1594(C = N); 1423 (C = S); 1109 
(COC). 1H NMR (400 MHZ, DMSO d6) σ (ppm): 
14.38(s, 1H, SH); 5.75 (m, 1H, H10); 5.85 (m, 1H, 
H9); 3.42(s, 1H, OH); 3.33(s, 1H, OH); 2.69-1.21 (m, 
32H, CH paraffinic); 0.84 (t, 3H, CH3 terminal). 
13C 
NMR (400 MHZ, DMSO d6) δ ppm: 180.7; 174.3; 
164.7; 144.28; 130.21; 70.27; 39.9; 37.6; 31.1; 29.3; 
26.7; 24.7; 24.4; 24.0; 22.5; 14.5. MS: Molecular for-
mula C19H34N2O2S: 354, m/z 279 (C19H34N); m/z 297 
(C19ON), m/z 75 (CNOS) and m/z 59 (CNS).
2.2.5. 5-Ricinoleyl-1,3,4-thiadiazole-2-thione 
The ricinoleic acid hydrazide (3), (1 g, 0.0032 
mole) was mixed with KOH (0.5 g) dissolved in abso-
lute ethanol. A solution of CS2 (2.5 g) was added to 
the mixture with 15 mL of ethanol. The mixture was 
stirred for 1 h at room temperature and then refluxed 
for 24 hours. The final product was acidified with 
hydrochloric acid. The resulting solid residue was 
filtered and recrystallized from ethanol. The product 
was obtained in the form of yellowish crystals (5), 
(1.45g, 75%); RF: 0.35 (cyclohexane /acetone 6/4); m.p. 
97 °C. UV (λmax) nm: 205; 285. IR (CCl4), ν cm
-1: 
3308.29(OH,NH); 2980.45(C = C); (2921.63,2849.31) 
(alkyl groups); 1589.06(C = N); 1462.74(C = S). 1H 
NMR (400 MHZ, DMSO d6) δ (ppm): 5.42 (s, 1H, 
NH); 5.33 (m, 1H, H10); 4. 75 (m, 1H, H9); 3.33 (s, 1H, 
OH); 3.32 (s, 1H, OH); 2.24-1.16 (m, 32H, CH par-
affinic); 0.84 (t, 3H, CH3 terminal). 13C NMR (400 
MHZ, DMSO d6) δ ppm: 174.9; 173.3; 130.8; 128.9; 
70.0; 64.4; 60.3; 37.9; 34.3; 31.9; 29.5; 25.7; 24.9; 22.5; 
14.5. MS: Molecular formula C19H34N2OS2: 364 m/z: 
364 (M+, 100%).
2.2.6. 5-Ricinoleyl-4-amino-1, 2, 4-triazole-3-thiol 
Ricinoleic acid hydrazide  (3), (1g; 0.0032 mol) 
and KOH (1.5 g) in absolute ethanol (10 mL) were 
mixed together until the solution became clear. CS2 
(25 mL) was added. The solution was stirred for 
10 h at room temperature, and then diethyl ether 
(20 mL) was added to form a precipitate ricinoyl- 
potassium thiocarbazinic acid (6). The intermediary 
product was mixed with (NH2NH2-H2O) (4 mL). 
The solution was refluxed for 15 h until the color 
of the solution became clear green. After cooling 
to room temperature, ice water (10 mL) was added 
to the reaction mixture, which was then neutralized 
with 3N HCl to form a precipitate. The precipitate 
was isolated by filtration and purified by recrystal-
lization from ethanol/water to afford the desired 
product in the form of yellow crystal: 5-Ricinoleyl-
4-amino-1, 2, 4-triazole-3-thiol  (7), 1.2g, 65%); 
Rf: 0.61 (cyclohexane /acetone: 6/4); Mp. (132˚C) 
UV (λ max) nm: 205; 240. IR (KBr), ν cm -1: 3417.24 
(OH); 3177 (NH2); 2953, 2868 (alkyl groups); 2700 
(SH); 1617 (C = N). 1H NMR (400 MHZ, DMSO 
d6) σ  (ppm): 11.97 (s, 1H, SH); 4.22 (d, 2H, NH2); 
4.01 (d, 2H, NH2); 5.75 (m, 1H, H10); 5.39 (m, 
1H, H9); 3.34 (s, 1H, OH); 2.69-1.23 (m, 32H, CH 
paraffinic); 0.85 (t, 3H, CH3 terminal). 
13C NMR 
(400 MHZ, DMSO d6) δ ppm: 181.0; 174.3; 164,7; 
128,2; 123,2; 70.0; 69.9; 60.3; 37.7; 31.9; 25.7; 22.5; 
14.5. MS: Molecular formula C19H36N4OS: 368; the 
pseudo-molecular peak [M + H] + with m / z 367.
2.2.7. N-Thiosemicarbazide ricinoleic 
Ricinoleic acid hydrazide  (3), 1g; 0.0032 mol) 
was dissolved in ethanol (20  mL) with stirring. 
Ammonium thiocyanate (0.58  g) and HCl (30%) 
were added, and the reaction mixture was refluxed 
for 6  h. Excess solvent was evaporated to almost 
dryness and recrystallized from methanol/petro-
leum ether to give N-Thiosemicarbazide ricinoleic 
(8), 0.97g, 65%)  ; Rf : 0,45 (cyclohexane /acetone: 
7/3)  ; Mp (97 °C) ; UV (λmax) nm: 210; 265. IR 
(KBr) ν cm-1: 3373.85 (OH); (3271.64, 3172.33, 
3106.76) (NH and NH2); (2851.24 and 2919.70) 
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(alkyl groups); 1699 (C = O); 1621 (C = O-N); 1492 
(C = S). 1H NMR (400 MHZ, DMSO d6) σ (ppm): 
8.87 (s, 1H, NH); 8.44 (s, 1H, NH); 4.32 (d,2H, 
NH2); 5.36 (m, 1H, H10 and H9); 3.33 (s, 1H, OH); 
2.68-1.21 (m, 32H, CH paraffinic); 0.84 (t, 3H, CH3 
terminal). 13C NMR (400 MHZ, DMSO d6) δ ppm: 
183.0; 178.4; 166.9; 164.7; 131.7; 127.5; 70.4; 69.9; 
37.6; 29.3; 29.3; 28.6; 25.5; 25.4; 25.2; 14.5. MS: 
Molecular formula C19H37N3O2S: 371, m/z: 371 
(M+, 100 %).
2.2.8. 5-Ricinoleyl-4H-1, 2, 4-triazole-3-thiol
N-Thiosemicarbazide ricinoleic (8), (1.0 g; 0.0024 
mol) in ethanol (15 mL) was added to an alcoholic 
solution of 10% NaOH (20 mL), and the reaction 
mixture was refluxed for 12  h. The mixture was 
cooled and acidified with dilute HCl to pH (5–6). 
The crude compound was recrystallized from etha-
nol to give white needle-like crystals: 5-Ricinoleyl-
4H-1,2,4-triazole-3-thiol (9), (0.75  g, 75%)  ; m.p. 
(95 °C) ; Rf: 0.46 (cyclohexane /acetone: 6/4)  ; UV 
(λmax) nm: 210. IR (KBr) ν cm-1: 3433 (OH, NH); 
3100(C = C); 2953 and 2868 (alkyl groups); 2722.05 
(SH); 1636. 3 (C = N). 1H NMR (400 MHZ, DMSO 
d6)  σ  (ppm): 12.34(s, 1H, SH); 4.57 (s, 1H, NH); 
5.75; 5.90 (m, 1H, H10 and H9); 3.72(s, 1H, OH); 
2.85-1.18  (m, 32H, CH paraffinic); 0.96 (t,  3H, 
CH3 terminal). 
13C NMR (400 MHZ, DMSO d6) δ 
ppm: 175.3; 174.7; 130.2; 125.2; 69.7; 39.9; 31.8; 
29.9; 25.2; 24.9; 22.9; 14.5. MS: Molecular formula 
C19H35N3OS: 353, The pseudo-molecular peak 
[M + H] + with m / z 354.
2.2.9. 5-Ricinoleyl-2-amino-1,3,4-oxadiazole
N-Thiosemicarbazide ricinoleic (8); (1.0 g, 0.0026 
mol) was dissolved in an alcoholic solution of NaOH 
(5N) with the aid of stirring. The mixture was refluxed 
at 80 °C, during which an aqueous iodine solution 
(KI / I2) was added gradually until the iodine color 
(pink-purple) persisted. Reflux was continued for 
15h. Once the solution had cooled, it was filtered and 
then treated with a dilute sodium thiosulfate solution 
and finally washed with distilled water to give a straw-
yellow solid which was recrystallized from ethanol 
to give 5-Ricinoleyl-2-amino-1,3,4-oxadiazole (10), 
(0.78g, 78%); m.p (128 °C); Rf : 0.56 (cyclohexane /
acetone : 6/4) ; UV (λmax) nm: 210; 275. IR (KBr), 
ν cm -1: 3389 (OH, NH2); 2921.63 and 2850.27 (alkyl 
groups); 165.45 (O-C = N); 1119 ( = C-O-C = ). 1H 
NMR (400 MHZ, DMSO d6) δ (ppm): 5.54 (d, 2H, 
NH2); 5.30 (m, 1H, H10); 5.23 (m, 1H, H9); 3.32(s, 1H, 
OH); 2.51-1.23 (m, 32H, CH paraffinic); 0.85 (t, 3H, 
CH3 terminal). 
13C NMR (400 MHZ, DMSO d6) δ 
ppm: 175.6; 174.9; 131.5; 125.5; 70.0; 37.3; 34.1; 31.9; 
31.2; 29.3; 28.6; 25.6; 25.2; 22.6; 14.5. MS: Molecular 
formula C19H35N3O2: 337, m/z 253 (C18H33O); m/z 279 
(C19H33CN); m/z 84 (C2HON3) and m/z 58 (CON2H2). 
2.2.10. 5-Ricinoleyl-2-amino-1,3,4-thiadiazole 11.
N-Thiosemicarbazide ricinoleic (8, 1.0 g; 0.0024 
mol) was added gradually under stirring to the cooled 
concentrated H2SO4 (30 mL) for 1 h. the reaction mix-
ture was refluxed for 10 h in an oil bath. The precipi-
tated solid was filtered, washed with water, dried and 
recrystallized with ethanol to give brown crystals (11, 
0.40g, 40%); m.p. (110 °C); Rf: 0.43 (cyclohexane /ace-
tone: 6/4) UV (λmax) nm: 210; 240. IR (KBr) ν cm-1: 
3444.24 (OH, NH2); 2955.38(C = C-CH); (2920.66 
and 2849.31) (alkyl groups); 1657.52 (S- C = N). 1H 
NMR (400 MHZ, DMSO d6) σ (ppm): 4.57 (d, 2H, 
NH2); 5.38 (m, 1H, H10); 5.57 (m, 1H, H9); 3.37 (s, 1H, 
OH); 2.58-1.16 (m, 32H, CH paraffinic); 0.82 (t, 3H, 
CH3 terminal). 
13C NMR (400 MHZ, DMSO d6) δ 
ppm: 174.3; 173.3; 134.6; 128.5; 69.7; 61.0; 60.03; 37.0; 
31.9; 29.4; 25.7; 25.2; 24.9; 22.9; 14.2. MS: Molecular 
formula C19H35N3OS: 353, m/z 279 (C19H33N); m/z 
227 (C13H21NOS); m/z 74 (CHN2S); m/z 59 (CH2N2). 
2.3. Biology
2.3.1. Antimicrobial activities
All the synthesized compounds were tested for 
their in vitro antimicrobial activity against the Gram 
positive bacteria Staphylococcus aureus (ATCC-
25923), Enterococcus faecalis (ATCC-29212), Bacillus 
cereus (ATCC  21332), the Gram-negative bacteria 
Pseudomonas aeruginosa (ATCC-27853), Escherichia 
coli (ATCC-25922), Klebsiella planticola (ATCC- 
33531), Salmonella, Proteus vulgarus (ATCC 29905), 
in the nutrient agar media and fungi Candida albi-
cans (ATCC 10231), Aspergillus niger (ATCC 
16404), Trichosporon Sp, Fusarium, Penicillium Sp 
and Altenaria in Sabouraud dextrose medium using 
the serial plate dilution method. The data for the 
minimum inhibitory concentrations (MIC) (10, 5, 
2.5, 1.25, 0.625) µg/mL were determined for those 
compounds which demonstrated activity in the pre-
liminary paper disk tests. The standard antibiotics 
ampicillin (10µg/disc) and amphotericin B (100µg/
disc) were used as reference drugs for the antibacte-
rial and antifungal activities, respectively.
2.3.2. Antioxidant activity (DPPH radical 
scavenging assay)
The DPPH solution was prepared in advance 
by dissolving 4 mg of  DPPH in 100 mL of  abso-
lute methanol. 0.1 mL of  each sample at different 
concentrations (65.5; 125; 250; 500; 1000) μg/mL 
were added to 3.9 mL of  DPPH. Reference anti-
oxidant solutions (ascorbic acid) were also pre-
pared under the same conditions to serve as a 
positive control. The negative control consisted 
only of  DPPH and methanol. The mixture was 
left in the dark for 30 min until discoloration. The 
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presence of  the DPPH radicals gave a dark purple 
color to the solution and which was absorbed rap-
idly at 517 nm when reduced. The color became 
pale yellow. During the reaction, the layer of  this 
radical became saturated on contact with an anti-
oxidant, which explained the disappearance of 
its coloring. This discoloration highlighted the 
trapping power of  the free radical by the tested 
product. The percentage of  the anti-free radical 
activity was estimated according to the equation 
below (Vijayalaxmi et al., 2015):
PI % = (Abs control - Abs product /Abs control) *100
PI: Percentage inhibition Abs control: 
Absorbance at the 517 nm wavelength of the nega-
tive control (DPPH + methanol).
2.3.3. α-Amylase inhibition activity
The α-amylase inhibitory activity of the synthetic 
compounds was determined using the chromogenic 
DNSA method with a few modifications (Adegboye 
et al., 2018). 300 μl of 0.02 M sodium phosphate buf-
fer (pH 6.9) containing α-amylase solution (0.5 mg/
mL) and 300 μl of sample at different concentrations 
(62.5; 125; 250; 500; 1000) μg/mL were incubated at 
37 °C for 30 min. Afterwards, 300 μl of a 1% starch 
solution in 0.02 M sodium phosphate buffer were 
added to each tube at timed intervals. The reaction 
mixtures were then incubated at 37 °C for 15 min. The 
reaction was stopped with 0.5 mL of dinitrosalicylic 
acid (DNSA) color reagent. The reaction mixture was 
then diluted after adding 5 mL of distilled water, and 
absorbance was measured at 540 nm. The α-amylase 
inhibitory activity was calculated as follows: 
Inhibition % = 1- (Asamp / Acont) 100%).
Where Asamp and Acont were defined as absorbance 
of the sample and the control, respectively. 
3. RESULTS AND DISCUSSION
3.1. Synthesis
The ricinoleiate triglyceride (1) was cata-
lytically transesterified with methanol to give 
methyl  ricinoleiate (2) in quantitative yield 
(Kumar et  al., 2017) and converted to hydra-
zide  (3) (Joshi et al., 2017), as summarized in 
Figure 1. Hydrazide (3) was subjected to synthetic 
modifications to reveal recinoleic diazoles and 
triazole derivatives: 1, 3,4-oxadiazole-5-thione 
(4), 1,3,4-thiadiazole-5-thione (5), 4-N-amino-
1,2,4-triazole-5-thiol (7), 1,2,4-triazole-5-thiol 
(9), 5-amino- 1,3,4-oxadiazole (10), 5-amino- 
1,3,4-thiadiazole (11) and as summarized in 
Figure 1. Conversion of ricinoleic triglyceride (1) to ricinoleic hydrazide (3).
Figure 2. Synthetic pathways to diazole and triazole derivatives (4), (5), (7), (9), (10) and (11) of  ricinoleic 
6 • F. Taieb Brahimi et al.
Grasas Aceites 71 (4), October–December 2020, e378. ISSN-L: 0017-3495 https://doi.org/10.3989/gya.0342191
Figure 3. Characteristic signals in H1NMR of heterocyclic derivatives: 5-Ricinoleyl-1,3,4-oxadiazole-2-thione-thiol (4) ¸ 
5-Ricinoleyl-1,3,4-thiadiazole-2-thione (5)¸ 5-Ricinoleyl-4-amino-1, 2, 4-triazole-3-thiol  (7)¸ 5-Ricinoleyl-4H-1,2,4-triazole-3-thiol 
(9)¸ 5-Ricinoleyl-2-amino-1,3,4-oxadiazole (10)¸ 5-Ricinoleyl-2-amino-1,3,4-thiadiazole  (11).
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figure  2. The first set of  heterocyle derivatives 
4, 5 and 7 were achieved by refluxing hydrazide 
3 with CS2 and aqueous KOH to give 2-ricin-
oleyl-1,3,4-oxadiazole-5-thiol (4) (Taieb Brahimi 
et al., 2017). While using the excess CS2 it yielded 
2-ricinoleyl-1,3,4-thiadiazole-5-thione (5) (Gad 
El-Karim et al., 2013). However, heating hydra-
zide (3) with CS2 in alcoholic KOH resulted in 
the crude ricinoleic potassium thiocarbazinic 
acid (6), which without separation and further 
analysis was refluxed with hydrazine hydrate 
to give  5-ricinoleyl-4- amino-1,2,4-triazole-3-
thiol (7)
The second set of  heterocycles (9-1)1 was pre-
pared from N-thiosemicarbazide ricinoleic (8), 
which had already been prepared by treating hydra-
zide (3) with ammonium thiocyanide. 5-Ricinoleyl-
4H-1,2,4-triazole-3-thiol (9) was obtained by the 
cyclization of  8 with KOH (Belkhadem et al., 
2017); while 2-amino oxadiazole (10) was isolated 
Table 1. Antibacterial activity of castor oil (1) and its synthesized derivatives (2-11).
Compound
Gram-positive bacteria Gram-negative bacteria
S.a. E.f. B.c. P.a. E.c. K.P. Sal. P.v.
Zone of inhibition in mm and MIC (minimum inhibitory concentration) in µg/mL
1 - - 7 (100) 7 (25) 7 (25) 8 (50) 10 (6.5) 10 (25)
2 - - 7 (50) 7 (25) 8 (25) 7 (50) 12 (25) 10 (25)
3 - - - - 10 (25) 10 (25) 15 (25) -
4 14 (6.25) 7 (50) - 7 (100) 10 (12.5) 10 (25) 15 (12.5) 8 (25)
5 10 (6.25) 12 (25) - - 8 (25) 10 (25) 10 (6.25) 8 (25)
7 7 (25) 9 (50) 7 (25) 7 (25) - 10 (25) 10 (25) -
8 25 (100) 7 (100) 7 (50) 8 (25) 10 (6.25) 8 (50) 10 (6.25) 10 (100)
9 7 (25) 7 (50) - 7 (50) 7 (25) 10 (25) 7 (50) 8 (25)
10 7 (50) 7 (12.5) 7 (50) 7 (50) - 8 (25) 10 (25) -
11 8 (50) 8 (50) 7 (100) 7 (100) - 10 (25) 10 (25) -
Amp 25 8 32 15 20 32 18 22
The figures in the table show the zone of inhibition (mm) and the corresponding MIC (µg/mL) values in brackets. 
Amp: Ampicillin (10 µg/ disc).
S.a. (Staphylococcus aureus), E.f. (Enterococcus faecalis), B.c. (Bacillus cereus), P.a. (Pseudomonas aeruginosa), 
E.c. (Escherichia coli), K.P. (Klebsiella planticola), Sal. (Salmonella)¸ P.v. (Proteus vulgarus).




Candida albicans Trichosporon Sp Aspergillus niger  Fusarium Penicillium Sp Altenaria
1 - - +++ - - +++
2 - - ++ - - +++
3 ++ ++ - + +++ -
4 ++ ++ - - - +
5 ++ ++ - - - +
7 +++ - - - - ++
8 - +++ - +++ +++ -
9 - - - - - +
10 ++ +++ - +++ - +++
11 - ++ - +++ - +++
Ref +++ ++ +++ + +++ +++
Key to the inhibition zones activities: Highly active = (21-30 mm) +++; Moderately active = (16-20 mm) ++; Slightly active = (10-15 mm) 
+; Inactive = (˂ 10mm) -
Ref: amphotericin B (100 μg/disc.).
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after treating 8 with NaOH in the presence of  I2/
KI. 2-Amino thiadiazole (11) was collected after 
reacting (8) with H3PO4. The structural determi-
nation of  all synthetic compounds 2-11 was con-
firmed spectroscopically by IR, UV, 1H- NMR, 
13C-NMR and MS (see Figure 3). All compounds 
1-11 became available, and a study of  their anti-
microbial, antioxidant and hypoglycemic activities 
was carried out. 
3.2. Pharmacological screening 
3.2.1. Antimicrobial activities 
The results for antimicrobial activities are sum-
marized in Tables 1 and 2.
The gram-positive bacteria under consideration 
showed zones of inhibition inferior to those observed 
by the Gram-negative bacteria. In general, the first 
Figure 4. DPPH scavenging effect (%) of castor oil and its synthesized derivatives at different concentrations of: 
(a) Intermediate compounds: Castor oil (1) ¸ Methyl ricinoleate (2) ¸ Ricinoleic acid hydrazide (3) ¸ N-Thiosemicarbazide ricinoleic 
(8) and ascorbic acid as reference. (B) Heterocyclic synthetic products: 5-Ricinoleyl-1,3,4-oxadiazole-2-thione-thiol (4)¸ 5-Ricinoleyl-
1,3,4-thiadiazole-2-thione  (5)¸ 5-Ricinoleyl-4-amino-1, 2, 4-triazole-3-thiol (7)¸ 5-Ricinoleyl-4H-1,2,4-triazole-3-thiol (9)¸ 
5-Ricinoleyl-2-amino-1,3,4-oxadiazole (10)¸ 5-Ricinoleyl-2-amino-1,3,4-thiadiazole  (11) and Ascorbic acid as reference. Each point 
shows the average value of three replicates ± SD. 
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site of action of the products tested on bacterial 
cells was the plasma membrane. This was directly 
related to the amphiphilic nature of the tested prod-
ucts which facilitated their insertion between the 
membrane phospholipids and ensured their solubi-
lization in the lipid bilayer (Soliman et al., 2015). 
The good activity was attributed to the presence 
of  pharmacologically active groups NH-CS-NH, 
C = O and C = S attached to the heterocyclic nuclei 
(triazoles, oxadiazoles and thiadiazoles). The pres-
ence of amine functions (NH2) provided the tested 
molecules a higher activity on mushrooms than 
those of other products.
3.2.2. Antioxidant activity
From a methodological point of view, the free 
radical test, 2,2-diphenyl-1- picrylhydrazyl radical 
(DPPH) is recommended for compounds contain-
ing the SH, NH and OH (Barbuceanu et al., 2014) 
groups and was carried out at ambient temperature. 
This made it possible to eliminate any risk of ther-
mal degradation of labile molecules (Li et al., 2018). 
This test consisted of the reduction of an alcoholic 
solution of the radical species DPPH● in the pres-
ence of a hydrogen donor antioxidant (AH), which 
resulted in the formation of a non-radical form of 
DPPH-H. Based on the experimental results (see 
Figure 4), the starting ricinoleic triglyceride (1), 
ester (2) and diazoles (4, 5, 7, 9, 10 and 11) showed 
high activity at different concentrations. Indeed, the 
structure-activity relationship of the heterocycle 
showed that the scavenging activity of the radicals 
increased with the presence of the hydrogen donor 
groups (-NH2, -NH, -SH, -OH).
 The conjuga-
tion between the free radicals of the hetero atoms 
(Nitrogen, Oxygen, Sulfur) and the π electrons of 
the aromatic ring represented an additional factor 
to increase the stability of the radical structure.
IC50 (Inhibitory concentration 50), also referred 
to as EC50 (Efficient Concentration 50), is the 
concentration of the test sample needed to reduce 
50% of the DPPH radical. The IC50 are calculated 
graphically by percent inhibition as a function 
of different concentrations of the tested product. 
From the value shown in Table 3, we noted a strong 
antiradical power for castor oil, which resulted in a 
fairly low IC50, comparable to that of the standard 
compound ascorbic acid. 
3.2.3. Hypoglycemic effect (α-amylase inhibition)
The digestive enzyme (α-amylase) was respon-
sible for hydrolyzing dietary starch (maltose), 
which broke down into glucose prior to absorp-
tion. The inhibition of  α-amylase led to a reduc-
tion in post prandial hyperglycemia under diabetic 
conditions (Yilmazer-Musa et al., 2012; Menteşe 
et al., 2014). α-Amylase activity can be measured 
in-vitro by the hydrolysis of  starch in the pres-
ence of  the α-amylases enzyme. The α-amylase 
inhibitory activity was determined by using dini-
tro salicylic acid (DNSA). Triglyceride (1), its 
corresponding ester (2), synthetic products 3-11 









(IC50 (μg/mL) (1/ IC50) (IC50 (μg/mL))
1 32,16 ± 0.58 0,031 130.42 ± 2.48
2 44,45 ± 0.45 0,022 120.25 ± 1.17
3 ND ND 400.64 ± 2.75
4 56,74 ± 0.32 0,019 325.90 ± 2.75
5 58,24 ± 0.30 0,020 552.80 ± 3.15
7 50,15 ± 0.41 0,018 736.00 ± 5.66
8 ND ND 125.00 ± 1.75
9 57,49 ± 0.35 0,017 920.56 ± 8.15
10 48,46 ± 0.28 0,001 ND
11 52,48 ± 0.38 0,001 ND
Ascorbic acid † 33,67 ± 0.45 0,030 -
Acarbose ‡ - - 85.65 ± 1.09
Each point shows the average value of three replicates ± SD
ND (Not detected). † (reference of antioxidant activity); ‡ (reference of anti diabetic activity).
DPPH (2, 2-diphenyl-1- picrylhydrazyl radical); IC50 (Inhibitory concentration 50).
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(except 6) and acarbose, as control, were evalu-
ated for in vitro α-amylase and showed a wide 
range of  inhibitory activity (Figure 5). At a lower 
IC50 concentration (μg/mL), the above mentioned 
compounds were grouped into three inhibitory 
groups: Group A, consisting of  compounds (1), 
(2) and (8), which exhibited an inhibition at the 
lowest corresponding concentrations (130.42 ± 
2.48, 120.25 ± 1.17 and 125.00 ± 1.75) μg/mL (see 
Table 3).
Group B, comprised of compounds (3) and (4), 
which showed inhibition at moderately higher con-
centrations (400.64 ± 2.75, 325.90 ± 2.75) μg/mL. 
Group C consisted of compounds (5), (7), and (9) at 
corresponded to the highest concentrations (552.80 
± 3.15, 736.00 ± 5.66, 920.56 ± 8.15) μg/mL. Among 
the synthetic compounds (4), (5), (7), (9), (10) and 
(11), no significant inhibitory effect was detected for 
the heterocycles (10) and (11). Oxadiazole 4 showed 
the best α-amylase inhibition. 
4. CONCLUSIONS
The oil extract (1) (ricinoleate triglyceride) reacted 
over 40% from original castor oil and was closest to 
highest percentage reported in the literature (45%) 
Figure 5. Percentage of α- amylase inhibition versus different concentration of:
(C) Intermediate products: Castor oil (1) ¸ Methyl ricinoleate (2), Ricinoleic acid hydrazide (3) ¸ N-Thiosemicarbazide ricinoleic (8) 
and Acarbose as reference. (D) Heterocyclic synthetic products: 5-Ricinoleyl-1,3,4-oxadiazole-2-thione-thiol (4) ¸ 5-Ricinoleyl-1,3,4-
thiadiazole-2-thione (5)¸ 5-Ricinoleyl-4-amino-1, 2, 4-triazole-3-thiol  (7)¸ 5-Ricinoleyl-4H-1,2,4-triazole-3-thiol (9)¸ 5-Ricinoleyl-2-
amino-1,3,4-oxadiazole (10)¸ 5-Ricinoleyl-2-amino-1,3,4-thiadiazole  (11) and Acarbose as reference. Each point shows the average 
value of three replicates ± SD.
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(Nakarmi et al., 2014). The synthetic compounds 
showed better biological effects on Gram-negative 
bacteria. The presence of amine functions (NH2) 
of the tested molecules provided all synthesized 
compounds with higher activity on mushrooms. All 
synthesized compounds showed high antioxidant 
activity. The  compounds with the greatest anti-
radical activity were noted as: Castor oil (1) ˃ Ester 
(2) ˃ Amino-oxadiazole (10) ˃ Amino-triazole (7) ˃ 
Amino-thiadiazole (11) ˃ oxadiazole (4) ˃ triazole 
(9) ˃ thiadiazole (11). The intermediate and diazole 
derivatives 1-11 were evaluated for in vitro α-amylase 
inhibitory activity and showed good to moderate 
inhibitory activity compared to standard acarbose. 
The synthesized compounds can be ranked in descend-
ing order  of their anti-diabetic activity as follows: 
Acarbose ˃  Ester (2) ˃  Castor oil (1) ˃  thiosemicarba-
zide (8) ˃ hydrazide (3) ˃ oxadiazole (4) ˃ thiadiazole 
(5) ˃ Amino-triazole (7) ˃ triazole (9)   ˃ Amino-
oxadiazole (10) ˃ Amino-thiadiazole (11).
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